NASDAQ · Key Statistics

NeuroSense Therapeutics Ltd. (NRSN) Key Statistics

$2.46 NASDAQ: NRSN Market Cap $4.67M

Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for NeuroSense Therapeutics Ltd. (NRSN), each with what it measures. Figures are trailing twelve months or the most recent reported period.

Valuation

Metric	Value
P/E ratioShare price divided by earnings per share.	-0.36
P/B ratioShare price divided by book value per share.	-2.10
P/S ratioMarket value divided by annual revenue.	0.00
PEG ratioP/E divided by the earnings growth rate.	-0.10
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.	-0.56
EV / RevenueEnterprise value against annual revenue.	0.00
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.	-232.56%
Free cash flow yieldFree cash flow as a percentage of market value.	-75.70%

Profitability

Metric	Value
Gross marginRevenue left after the direct cost of goods sold.	0.00%
Operating marginRevenue left after operating costs.	0.00%
Net marginRevenue left after every cost, including tax and interest.	0.00%
Return on equityProfit as a percentage of shareholders’ equity.	723.04%
Return on assetsProfit as a percentage of total assets.	-853.16%
Return on capital employedOperating profit against the capital the business uses.	587.30%

Financial health

Metric	Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.	0.31
Quick ratioThe same, excluding inventory.	0.31
Debt to equityTotal borrowings against shareholders’ equity.	-0.11
Debt to assetsTotal borrowings against total assets.	0.00
Interest coverageHow many times operating profit covers the interest bill.	-1028.12

Per share and size

Metric	Value
Earnings per shareProfit attributable to each share.	$-8.80
Shares outstandingShares currently issued.	0
Market capitalisationShare price times shares outstanding.	$4.67M
EmployeesReported headcount.	17

Dividend

Metric	Value
Dividend yieldAnnual dividend as a percentage of the share price.	0.00%

NeuroSense Therapeutics Ltd. (NRSN) statistics — frequently asked questions

What is NeuroSense Therapeutics Ltd.'s P/E ratio?

NeuroSense Therapeutics Ltd. (NRSN) trades on a price-to-earnings ratio of -0.36. A negative P/E means the company reported a loss, so the ratio is not a meaningful valuation measure.

What is NeuroSense Therapeutics Ltd.'s return on equity?

NeuroSense Therapeutics Ltd. (NRSN) reports a return on equity of 723.04%, meaning it generated that much profit for every dollar of shareholders' equity.

How much debt does NeuroSense Therapeutics Ltd. carry?

NeuroSense Therapeutics Ltd. (NRSN) has a debt-to-equity ratio of -0.11, which compares total borrowings with shareholders' equity.

Related stock screens

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks High ROE Stocks Low P/E Stocks High Net Margin Stocks Dividend Stocks Low Debt Stocks Nasdaq High ROE Stocks All stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.